Medications for Hospital Acquired Pneumonia

7 results

  • ciprofloxacin in dextrose

    (ciprofloxacin)
    Hospira, Inc.
    Ciprofloxacin Injection is indicated for treating various infections in adults, including skin, bone and joint, complicated intra-abdominal, nosocomial pneumonia, febrile neutropenia, inhalational anthrax (post-exposure), plague, chronic bacterial prostatitis, lower respiratory tract infections, complicated urinary tract infections, and acute sinusitis.

  • levofloxacin

    (Levofloxacin)
    Hospira, Inc
    Levofloxacin Injection is indicated for treating mild to severe infections in adults, including nosocomial and community-acquired pneumonia, skin infections, chronic bacterial prostatitis, inhalational anthrax, plague, and complicated urinary tract infections. It is used when intravenous administration is preferred due to patient conditions.

  • piperacillin and tazobactam

    (piperacillin and tazobactam)
    Armas Pharmaceuticals Inc.
    Piperacillin and tazobactam is indicated for treating intra-abdominal infections, nosocomial pneumonia, skin and skin structure infections, female pelvic infections, and moderate community-acquired pneumonia in adults and pediatric patients (2 months and older), specifically targeting beta-lactamase producing bacteria.

  • piperacillin and tazobactam

    (Piperacillin and Tazobactam)
    Sandoz Inc
    Piperacillin and tazobactam for injection is indicated for treating intra-abdominal infections, nosocomial pneumonia, skin infections, female pelvic infections, and community-acquired pneumonia in patients aged 2 months and older. It targets infections caused by beta-lactamase producing bacteria, aiming to reduce drug resistance.

  • piperacillin and tazobactam

    (piperacillin and tazobactam)
    Armas Pharmaceuticals Inc.
    Piperacillin and tazobactam is indicated for treating intra-abdominal and nosocomial pneumonia in adults and pediatric patients, as well as skin infections, female pelvic infections, and moderate community-acquired pneumonia, particularly when caused by specific beta-lactamase producing bacteria. It should be used judiciously to prevent drug resistance.

  • piperacillin and tazobactam

    (piperacillin sodium and tazobactam sodium)
    Civica, Inc.
    Piperacillin and tazobactam is indicated for treating intra-abdominal infections, nosocomial pneumonia, skin infections, female pelvic infections, and community-acquired pneumonia in patients 2 months and older, specifically those caused by beta-lactamase producing bacteria. It aims to reduce drug-resistant bacteria development.

  • vibativ

    (telavancin hydrochloride)
    Cumberland Pharmaceuticals Inc.
    VIBATIV is indicated for adults with complicated skin and skin structure infections (cSSSI) and hospital-acquired or ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible Gram-positive organisms, including methicillin-susceptible and -resistant Staphylococcus aureus. It may be used as empiric therapy in certain cases.